SQZ Biotechnologies Co (SQZB)
0.021
0.00 (0.00%)
USD |
OTCM |
May 17, 15:23
SQZ Biotechnologies Profit Margin (Quarterly): -9.42K% for June 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -9.42K% |
| March 31, 2023 | |
| December 31, 2022 | -112.7% |
| September 30, 2022 | -723.4% |
| June 30, 2022 | -739.2% |
| March 31, 2022 | -733.3% |
| December 31, 2021 | -95.72% |
| September 30, 2021 | -472.1% |
| Date | Value |
|---|---|
| June 30, 2021 | -420.1% |
| March 31, 2021 | -282.3% |
| December 31, 2020 | -707.7% |
| September 30, 2020 | -201.8% |
| June 30, 2020 | -167.0% |
| March 31, 2020 | -165.1% |
| December 31, 2019 | -164.3% |
| September 30, 2019 | -194.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-9.42K%
Minimum
Jun 2023
-95.72%
Maximum
Dec 2021
-973.4%
Average
-282.3%
Median
Mar 2021
Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -19.35K% |
| IGC Pharma Inc | -2.74K% |
| NovaBay Pharmaceuticals Inc | -122.2% |
| Protalix BioTherapeutics Inc | -122.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -126.8% |
| Return on Assets | -62.81% |
| Return on Invested Capital | -126.8% |
| Operating Margin (Quarterly) | -9.61K% |
| Return on Net Operating Assets | -162.8% |